Marzulene


Indications and Reactions:

Role Indications Reactions
Secondary
Nasopharyngitis 18.9%
Flank Pain 12.2%
Hypertension 10.8%
Oropharyngeal Pain 8.1%
Cellulitis 5.4%
Chronic Hepatitis C 5.4%
Influenza 5.4%
Upper Respiratory Tract Inflammation 5.4%
Nausea 4.1%
Pain 4.1%
Pyrexia 4.1%
Drug Use For Unknown Indication 2.7%
Gastritis 2.7%
Pharyngitis 2.7%
Trigeminal Neuralgia 2.7%
Angina Pectoris 1.4%
Atrial Fibrillation 1.4%
Insomnia 1.4%
Renal Failure 1.4%
Nausea 14.3%
Blood Pressure Increased 9.5%
Haematochezia 9.5%
Rash 9.5%
Stevens-johnson Syndrome 9.5%
Cardiomyopathy 4.8%
Drug Interaction 4.8%
Eosinophilia 4.8%
Hepatitis C Positive 4.8%
Human Herpes Virus 6 Serology Positive 4.8%
Loss Of Consciousness 4.8%
Memory Impairment 4.8%
Pleural Effusion 4.8%
Pneumonia Legionella 4.8%
White Blood Cell Count Increased 4.8%
Concomitant
Rheumatoid Arthritis 22.9%
Prophylaxis 14.1%
Hypertension 7.8%
Multiple Myeloma 6.7%
Gastritis 6.1%
Drug Use For Unknown Indication 5.9%
Gastric Ulcer 4.3%
Behcet's Syndrome 4.2%
Constipation 3.5%
Herpes Zoster 2.9%
Osteoporosis 2.8%
Product Used For Unknown Indication 2.8%
Hepatitis C 2.5%
Hepatic Neoplasm Malignant 2.3%
Infection Prophylaxis 2.3%
Cerebral Infarction 2.2%
Angina Pectoris 1.9%
Gastritis Prophylaxis 1.8%
Cardiac Failure Chronic 1.5%
Depression 1.5%
Pyrexia 10.9%
Pneumonia 8.0%
Rhabdomyolysis 7.3%
Platelet Count Decreased 6.6%
Disseminated Tuberculosis 5.8%
Renal Impairment 5.8%
Sepsis 5.8%
Thrombocytopenia 5.1%
Anosmia 4.4%
Interstitial Lung Disease 4.4%
Therapeutic Response Decreased 4.4%
White Blood Cell Count Decreased 4.4%
Pulmonary Alveolar Haemorrhage 3.6%
Systemic Lupus Erythematosus 3.6%
Toxic Epidermal Necrolysis 3.6%
Toxic Skin Eruption 3.6%
White Blood Cell Count Increased 3.6%
Brain Abscess 2.9%
Cerebral Infarction 2.9%
Hallucination 2.9%

Drug Data